What do systematic reviews say?

Seizure freedom · people with newly diagnosed epilepsy

Proportion of participants seizure‐free at 24 months after randomization ‐ not reported · people with newly diagnosed epilepsy

50% or greater reduction in seizure frequency · people with newly diagnosed epilepsy

Adverse events during treatment period · people with newly diagnosed epilepsy

Proportion of participants with treatment‐emergent adverse events (TEAEs) ‐ Leading to discontinuation during the treatment period № of participants: 36 (1 RCT) · people with newly diagnosed epilepsy